It is January 2014, and the case protagonist, David Milestone (senior advisor in the Center for Accelerating Innovation and Impact at the U.S. Agency for International Development's Global Health Bureau), is preparing for a meeting of global stakeholders and pharmaceutical producers who are considering reducing mortality caused by childhood pneumonia and are prepared to donate $10 million to support this attempt. The aim of landmark is to propose a strategy to deal with childhood pneumonia in Uganda, toward which the $10 million contribution would go.
In addition to effectively and sustainably reducing childhood pneumonia deaths, the program must align the interests of numerous stakeholders on the other side of the issue. An effective strategy in Uganda could be a model for interventions elsewhere. The United Nations Commission on Lifesaving Commodities for Women and Children recently identified Uganda as a "pathfinder" nation, meaning it might serve as the example for other states wrestling with the exact same issues. It is an exceptional opportunity to alter the lives of children in Uganda-and all around the world.
PUBLICATION DATE: January 05, 2015 PRODUCT #: KEL874-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Interview with Dennis Bender–Habitat for Humanity International Video
Gorenje D.D.: Slovenian Manufacturer Confronts the European Market
Genetic Testing and the Puzzles We Are Left To Solve (D)
Genetic Testing and the Puzzles We Are Left To Solve (I)
Note on the Human Genome Project
Apple Computer (A): Industry Strategy and Organization
Meta-Decision Approach
Implementation of a Hybrid Operating Room for Cardiac Surgery at the Sainte-Justine University Hospital: Collaboration and Change Management Challenges
Pulmocit (B): Negotiating Pharmaceutical Products with the Government
A Sought-After Visa For Entering China’s Electronic Payment Market and Strategies Beyond
